Assessment of the anti-hyperglycaemic, anti-inflammatory and antioxidant activities of the methanol extract of moringa oleifera in diabetes-induced nephrotoxic male wistar rats

Molecules

Volumn 22, Issue 4, 2017, Pages

  Omodanisi, Elizabeth I ^a   Aboua, Yapo G ^a   Oguntibeju, Oluwafemi O ^a   Lamuela Raventós, Rosa M ^b  

^a CAPE PENINSULA UNIVERSITY OF TECHNOLOGY   (South Africa)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; INTERLEUKIN 6; METHANOL; PLANT EXTRACT; STREPTOZOCIN;

ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; KIDNEY; LIPID PEROXIDATION; MALE; METABOLISM; MORINGA OLEIFERA; RANDOMIZATION; RAT; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYPOGLYCEMIC AGENTS; INTERLEUKIN-6; KIDNEY; LIPID PEROXIDATION; MALE; METHANOL; MORINGA OLEIFERA; PLANT EXTRACTS; RANDOM ALLOCATION; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 85016251301     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules22040439     Document Type: Article

References (82)

1. Gupta, R.; Mathur, M.; Bajaj, V.K.; Katariya, P.; Yadav, S.; Kamal, R.; Gupta, R.S. Evaluation of antidiabetic and antioxidant activity of Moringa oleifera in experimental diabetes. J. Diabetes 2012, 4, 164-171.
2. Forbes, J.M.; Cooper, M.E. Mechanisms of diabetic complications. Physiol. Rev. 2013, 93, 137-188.
3. Matough, F.A.; Budin, S.B.; Hamid, Z.A.; Alwahaibi, N.; Mohamed, J. The role of oxidative stress and antioxidants in diabetic complications. Sult. Qaboos Univ. Med. J. 2012, 12, 5-18.
4. Mathers, C.D.; Loncar, D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006, 3.
5. Donath, M.Y.; Shoelson, S.E. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 2011, 11, 98-107.
6. Jaiswal, D.; Rai, P.K.; Mehta, S.; Chatterji, S.; Shukla, S.; Rai, D.K.; Sharma, G.; Sharma, B.; Watal, G. Role of Moringa oleifera in regulation of diabetes-induced oxidative stress. Asian Pac. J. Trop. Med. 2013, 6, 426-432.
7. Mimić-Oka, J.; Simić, D.V.; Simić, T.P. Free radicals in cardiovascular diseases. Med. Biol. 1999, 6, 11-22.
8. McCune, L.M.; Johns, T. Antioxidant activity in medicinal plants associated with the symptoms of diabetes mellitus used by the Indigenous Peoples of the North American boreal forest. J. Ethnopharmacol. 2002, 82, 197-205.
9. Sharma, P.; Jha, A.B.; Dubey, R.S.; Pessarakli, M. Reactive oxygen species, oxidative damage, and antioxidative defense mechanism in plants under stressful conditions. J. Bot. 2012, 1-26.
10. Kowluru, R.A.; Chan, P.S. Oxidative stress and diabetic retinopathy. J. Diabetes Res. 2007.
11. Baynes, J.W. Role of oxidative stress in development of complications in diabetes. Diabetes 1991, 40, 405-412.
12. Halliwell, B. Oxidative stress and neurodegeneration: Where are we now? J. Neurochem. 2006, 97, 1634-1658.
13. Halliwell, B. Role of free radicals in the neurodegenerative diseases. Drugs Aging 2001, 18, 685-716.
14. Dandona, P.; Aljada, A.; Bandyopadhyay, A. Inflammation: The link between insulin resistance; obesity and diabetes. Trends Immunol. 2004, 25, 4-7.
15. Singh, V.P.; Bali, A.; Singh, N.; Jaggi, A.S. Advanced glycation end products and diabetic complications. Korean J. Physiol. Pharmacol. 2014, 18, 1-14.
16. Ansari, N.A.; Dash, D. Amadori glycated proteins-role in production of autoantibodies in diabetes mellitus and effect of inhibitors on non-enzymatic glycation. Aging Dis. 2013, 4, 50-56.
17. Bonnefont-Rousselot, D. Glucose and reactive oxygen species. Curr. Opin. Clin. Nutr. Metab. Care 2002, 5, 561-568.
18. Gupta, R.; Dubey, D.K.; Kannan, G.M.; Flora, S.J.S. Concomitant administration of Moringa oleifera seed powder in the remediation of arsenic-induced oxidative stress in mouse. Cell Biol. Int. 2007, 31, 44-56.
19. Stohs, S.J.; Hartman, M.J. Review of the safety and efficacy of Moringa oleifera. Phyther. Res. 2015, 29, 796-804.
20. Hussain, S.; Malik, F.; Mahmood, S. An exposition of medicinal preponderance of Moringa oleifera (Lank). Pak. J. Pharm. Sci. 2014, 27, 397-403.
21. Ajit, K.; Choudhary, B.K.; Bandyopadhyay, N.G. Comparative evaluation of hypoglycaemic activity of some Indian medicinal plants in alloxan diabetic rats. J. Ethnopharmacol. 2002, 84, 105-108.
22. Rao, K.S.; Misra, S.H. Anti-inflammatory and anti-hepatotoxic activities of the rats of Moringa pterygosperma Geaertn. Indian J. Pharm. Sci. 1998, 60, 12-16.
23. Soliman, G.Z.A. Anti-diabetic activity of dried Moringa oleifera leaves in normal and streptozotocin (STZ)-induced diabetic male rats. Indian J. Appl. Res. 2013, 3, 18-23.
24. Afshari, A.T.; Shirpoor, A.; Farshid, A.; Saadatian, R.; Rasmi, Y.; Saboory, E.; Ilkhanizadeh, B.; Allameh, A. The effect of ginger on diabetic nephropathy, plasma antioxidant capacity and lipid peroxidation in rats. Food Chem. 2007, 101, 148-153.
25. Kukreja, R.C.; Hess, M.L. The oxygen free radical system: From equations through membrane-protein interactions to cardiovascular injury and protection. Cardiovasc. Res. 1992, 26, 641-655.
26. Sena, L.A.; Chandel, N.S. Physiological roles of mitochondrial reactive oxygen species. Mol. Cell 2012, 48, 158-167.
27. Nasri, H.; Baradaran, A.; Shirzad, H.; Rafieian-Kopaei, M. New concepts in nutraceuticals as alternative for pharmaceuticals. Int. J. Prev. Med. 2014, 5, 1487-1499.
28. Valko, M.; Leibfritz, D.; Moncol, J.; Cronin, M.T.; Mazur, M.; Telser, J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39, 44-84.
29. Al-malki, A.L.; El-Rabey, H.A. The antidiabetic effect of low doses of Moringa oleifera Lam. seeds on streptozotocin induced diabetes and diabetic nephropathy in male rats. BioMed Res. Int. 2015.
30. Fahey, J.W. Moringa oleifera: A review of the medical evidence for its nutritional, therapeutic, and prophylactic properties. Part 1. Trees Life J. 2005, 1, 1-5.
31. Mehta, J.; Shukla, A.; Bukhariya, V.; Charde, R.; Road, R. The magic remedy of Moringa oleifera: An overview. Int. J. Biomed. Adv. Res. 2011, 2, 1-13.
32. Dièye, A.M.; Sarr, A.; Diop, S.N.; Ndiaye, M.; Sy, G.Y.; Diarra, M.; Faye, B. Medicinal plants and the treatment of diabetes in Senegal: Survey with patients. Fundam. Clin. Pharmacol. 2008, 22, 211-216.
33. Farooq, F.; Rai, M.; Tiwari, A.; Khan, A.A.; Farooq, S. Medicinal properties of Moringa oleifera: An overview of promising healer. J. Med. Plants Res. 2012, 6, 4368-4374.
34. Luqman, S.; Srivastava, S.; Kumar, R.; Maurya, A.K.; Chanda, D. Experimental assessment of Moringa oleifera leaf and fruit for its antistress, antioxidant, and scavenging potential using in vitro and in vivo assays. Evid. Based Complement. Altern. Med. 2012.
35. Edoga, C.O.; Njoku, O.O.; Amadi, E.N.; Okeke, J.J. Blood sugar lowering effect of Moringa oleifera Lam in albino rats. Int. J. Sci. Technol. 2013, 3, 88-90.
36. Singh, R.G.; Negi, P.S.; Radha, C. Phenolic composition, antioxidant and antimicrobial activities of free and bound phenolic extracts of Moringa oleifera seed flour. J. Funct. Foods 2013, 5, 1883-1891.
37. Siddhuraju, P.; Becker, K. Antioxidant properties of various solvent extracts of total phenolic constituents from three different agroclimatic origins of drumstick tree (Moringa oleifera Lam.) leaves. J. Agric. Food Chem. 2003, 51, 2144-2155.
38. Iwara, I.A.; Otu, E.A.; Efiong, E.E.; Igile, G.O.; Mgbeje, B.I.A.; Ebong, P.E. Evaluation of the nephroprotective effects of combined extracts of Vernonia amygdalina and Moringa oleifera in diabetes induced kidney injury in albino Wistar rats. Sch. J. Appl. Med. Sci. 2013, 1, 881-886.
39. Koul, B.; Chase, N.J. Moringa oleifera Lam: Panacea to several maladies. J. Chem. Pharm. Res. 2015, 7, 687-707.
40. Nishikawa, T.; Araki, E. Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxid. Redox Signal. 2007, 9, 343-353.
41. Sharma, K.; Ziyadeh, F.N. Hyperglycemia and diabetic kidney disease: The case for transforming growth factor-β as a key mediator. Diabetes 1995, 44, 1139-1146.
42. Mbikay, M. Therapeutic potential of Moringa oleifera leaves in chronic hyperglycemia and dyslipidemia: A review. Front. Pharmacol. 2012, 3, 24.
43. Ezuruike, U.F.; Prieto, J.M. The use of plants in the traditional management of diabetes in Nigeria: Pharmacological and toxicological considerations. J. Ethnopharmacol. 2014, 155, 857-924.
44. Akbarzadeh, A.; Norouzian, D.; Mehrabi, M.R.; Jamshidi, S.; Farhangi, A.; Verdi, A.A. Induction of diabetes by streptozotocin in rats. Indian J. Clin. Biochem. 2007, 22, 60-64.
45. Novío, S.; Nfflçez, M.J.; Amigo, G.; Freire-garabal, M. Effects of fuoxetine on the oxidative status of peripheral blood leucocytes of restraint-stressed mice. Basic Clin. Pharmacol. Toxicol. 2011, 109, 365-371.
46. Ayepola, O.R.; Chegou, N.N.; Brooks, N.L.; Oguntibeju, O.O. Kolaviron, a Garcinia biflavonoid complex ameliorates hyperglycemia-mediated hepatic injury in rats via suppression of inflammatory responses. BMC Complement. Altern. Med. 2013, 13, 363-372.
47. Yassa, H.D.; Tohamy, A.F. Extract of Moringa oleifera leaves ameliorates streptozotocin-induced diabetes mellitus in adult rats. Acta Histochem. 2014, 116, 844-854.
48. Toma, A.; Makonnen, E.; Debella, A.; Tesfaye, B. Antihyperglycemic effect on chronic administration of Butanol fraction of ethanol extract of Moringa stenopetala leaves in alloxan induced diabetic mice. Asian Pac. J. Trop. Biomed. 2012, 2, 1606-1610.
49. American Diabetes Association. Diabetic nephropathy. Diabetes Care 1998, 21, 50-53.
50. Navarro-González, J.F.; Mora-Fernández, C. The role of inflammatory cytokines in diabetic nephropathy. J. Am. Soc. Nephrol. 2008, 19, 433-442.
51. Vlassara, H.; Palace, M.R. Diabetes and advanced glycation end products. J. Intern. Med. 2002, 251, 87-101.
52. Thomas, R.; Kanso, A.; Sedor, J.R. Chronic kidney disease and its complications. Prim. Care 2008, 35, 329-344.
53. Rodríguez-Pérez, C.; Quirantes-Piné, R.; Fernández-Gutiérrez, A.; Segura-Carretero, A. Optimization of extraction method to obtain a phenolic compounds-rich extract from Moringa oleifera Lam leaves. Ind. Crops Prod. 2015, 66, 246-254.
54. Ayeleso, A.; Brooks, N.; Oguntibeju, O.O. Modulation of antioxidant status in streptozotocin-induced diabetic male Wistar rats following intake of red palm oil and/or rooibos. Asian Pac. J. Trop. Med. 2014, 7, 536-544.
55. Valdez-Solana, M.A.; Mejía-García, V.Y.; Téllez-Valencia, A.; García-Arenas, G.; Salas-Pacheco, J.; Alba-Romero, J.J.; Sierra-Campos, E. Nutritional content and elemental and phytochemical analyses of Moringa oleifera grown in mexico. J. Chem. 2015, 2015, 1-9.
56. Ndong, M.; Uehara, M.; Katsumata, S.I.; Suzuki, K. Effects of oral administration of Moringa oleifera lam on glucose tolerance in goto-kakizaki and Wistar rats. J. Clin. Biochem. Nutr. 2007, 40, 229-233.
57. Roopalatha, U.C.; Mala, V.N. Phytochemical analysis of successive reextracts of the leaves of Moringa oleifera lam. Int. J. Pharm. Pharm. Sci. 2013, 5, 1-6.
58. Verma, A.R.; Vijayakumar, M.; Mathela, C.S.; Rao, C.V. In vitro and in vivo antioxidant properties of different fractions of Moringa oleifera leaves. Food Chem. Toxicol. 2009, 47, 2196-2201.
59. Alhakmani, F.; Kumar, S.; Khan, S.A. Estimation of total phenolic content, in-vitro antioxidant and anti-inflammatory activity of flowers of Moringa oleifera. Asian Pac. J. Trop. Biomed. 2013, 3, 623-627.
60. Kumar, B.; Gupta, S.K.; Nag, T.C.; Srivastava, S.; Saxena, R.; Jha, K.A.; Srinivasan, B.P. Retinal neuroprotective effects of quercetin in streptozotocin-induced diabetic rats. Exp. Eye Res. 2014, 125, 193-202.
61. Buckham Sporer, K.R.; Weber, P.S.; Burton, J.L.; Earley, B.; Crowe, M.A. Transportation of young beef bulls alters circulating physiological parameters that may be effective biomarkers of stress. J. Anim. Sci. 2008, 86, 1325-1334.
62. Santos, A.F.S.; Argolo, A.C.C.; Paiva, P.M.G.; Coelho, L.C.B.B. Antioxidant activity of Moringa oleifera tissue extracts. Phyther. Res. 2012, 26, 1366-1370.
63. Patel, D.; Kumar, R.; Laloo, D.; Hemalatha, S. Diabetes mellitus: An overview on its pharmacological aspects and reported medicinal plants having antidiabetic activity. Asian Pac. J. Trop. Biomed. 2012, 2, 411-420.
64. Smith, R.A.; Hartley, R.C.; Cocheme, H.M.; Murphy, M.P. Mitochondrial pharmacology. Trends Pharmacol. Sci. 2012, 33, 341-352.
65. Manohar, V.S.; Jayasree, T.; Kishore, K.K.; Rupa, L.M.; Dixit, R. Evaluation of hypoglycemic and antihyperglycemic effect of freshly prepared aqueous extract of Moringa oleifera leaves in normal and diabetic rabbits. J. Chem. Pharm. Res. 2012, 4, 249-253.
66. Farombi, E.O.; Abolaji, A.O.; Adedara, I.A.; Maduako, I.; Omodanisi, I. Artemisinin induces hormonal imbalance and oxidative damage in the erythrocytes and uterus but not in the ovary of rats. Hum. Exp. Toxicol. 2015, 34, 83-92.
67. Naugler, W.E.; Karin, M. The wolf in sheep's clothing: The role of interleukin-6 in immunity, inflammation and cancer. Trends Mol. Med. 2008, 14, 109-119.
68. Seca, A.M.L.; Grigore, A.; Pinto, D.C.G.; Silva, A.M.S. The genus Inula and their metabolites: From ethnopharmacological to medicinal uses. J. Ethnopharmacol. 2014, 154, 286-310.
69. Orellana-Gavaldà, J.M.; Herrero, L.; Malandrino, M.I.; Paneda, A.; Sol Rodríguez-Peña, M.; Petry, H.; Asins, G.; Van Deventer, S.; Hegardt, F.G.; Serra, D. Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation. Hepatology 2011, 53, 821-832.
70. Adisakwattana, S.; Ruengsamran, T.; Kampa, P.; Sompong, W. In vitro inhibitory effects of plant-based foods and their combinations on intestinal α-glucosidase and pancreatic α-amylase. BMC Complement. Altern. Med. 2012, 12.
71. Williams, M.D.; Nadler, J.L. Inflammatory mechanisms of diabetic complications. Curr. Diab. Rep. 2007, 7, 242-248.
72. Kandasamy, N.; Ashokkumar, N. Myricetin modulates streptozotocin-cadmium induced oxidative stress in long term experimental diabetic nephrotoxic rats. J. Funct. Foods 2013, 5, 1466-1477.
73. Ou, B.; Hampsch-Woodill, M.; Prior, R. Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe. J. Agric. Food Chem. 2001, 49, 4619-4626.
74. Benzie, I.F.F.; Strain, J.J. The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: The FRAP assay. Anal. Biochem. 1999, 239, 70-76.
75. Re, R.; Pellegrini, N.; Proteggente, A.; Pannala, A.; Yang, M.; Rice-Evans, C. Antioxidant activity applying an improved ABTS radical cation decolourization assay. Free Radic. Biol. Med. 1999, 26, 1231-1237.
76. Singleton, V.L.; Orthofer, R.; Lamuela-Raventós, R.M. Analysis of total phenols and other oxidation substrates and antioxidants by means of folin-ciocalteu reagent. Meth. Enzymol. 1999, 299, 152-178.
77. Mazza, G.; Fuumoto, L.; Delaquis, P.; Girard, B.; Ewert, B. Anthocyanins, phenolics, and colour of Cabernet Frkanc, Merlot, and Pinot Noir wines from British Columbia. J. Agric. Food Chem. 1999, 47, 4009-4017.
78. Khoschsorur, G.A.; Winklhofer-Raab, B.M.; Rabl, H.; Auer, T.; Peng, Z.; Schau, R.J. Evaluation of a sensitive HPLC method for the determination of malondialdehyde, and application of the method to different biological materials. Chromatographia 2000, 52, 181-184.
79. Crosti, N.; Servidei, T.; Bajer, J.; Serra, A. Modification of the 6-hydroxydopamine technique for the correct determination of superoxide dismutase. J. Clin. Chem. Clin. Biochem. 1987, 25, 265-266.
80. Aebi, H. Catalase in vitro. Meth. Enzymol. 1984, 105, 121-126.
81. Asensi, M.J.; Sastre, V.; Pollardor, A.; Lloret, A.; Lehner, M.; Garcia-de-la Asuncion, J.; Viña, J. Ratio of reduced to oxidized glutathione as an indicator of oxidative stress status and DNA damage. Meth. Enzymol. 1999, 299, 267-277.
82. Ellerby, L.M.; Bredesen, D.E. Measurement of cellular oxidation, reactive oxygen species, and antioxidant enzymes during apoptosis. Meth. Enzymol. 2000, 322, 413-421.